Medication info

Ocostan Tablets (Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›50mg / 1 tablet
Manufacturer / importer
Os Korea Pharmaceutical Co., Ltd.
Appearance
White oval film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201603794 · Approved 2016.06.23

Summary

Main use
Treatment of hypertension and nephropathy in patients with type 2 diabetes accompanied by hypertension
Who takes it
Adults · Children
Adult dose
This medicine may be taken with or without food, but it is recommended that it be taken at the same time every day. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be administered orally in 2 divided doses daily or, if necessary, increased to 100 mg once daily. 3) If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used glucose-lowering agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient populations 1) Elderly patients No adjustment of the initial dose is required in elderly patients aged 75 years or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. 2) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is required. (2) Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this medicine once daily is recommended. 3) Patients with reduced effective intravascular volume For patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). 4) Patients with hepatic impairment For patients with a history of hepatic impairment, consider administering a lower dose. Do not administer to patients with severe hepatic impairment.
Child dose
Children and adolescents 6 years of age and older weighing 20 kg or more and less than 50 kg who can swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents 6 years of age and older weighing 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Pediatric patients under 6 years of age, pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡, and pediatric patients with hepatic impairment: Not recommended.

Ingredients

Manufacturer
Os Korea Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of hypertension and nephropathy in patients with type 2 diabetes accompanied by hypertension

  • Hypertension
  • kidney disease
View approved original text

This medication is used to treat high blood pressure. It acts effectively even in patients with hypertension who also have kidney disease accompanying type 2 diabetes. Thus, it helps to reduce the risk of cardiovascular diseases and kidney complications related to hypertension. This medication is used to stabilize blood pressure and improve overall health.

How to take

Adult dose

This medicine may be taken with or without food, but it is recommended that it be taken at the same time every day. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be administered orally in 2 divided doses daily or, if necessary, increased to 100 mg once daily. 3) If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used glucose-lowering agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient populations 1) Elderly patients No adjustment of the initial dose is required in elderly patients aged 75 years or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. 2) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is required. (2) Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this medicine once daily is recommended. 3) Patients with reduced effective intravascular volume For patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). 4) Patients with hepatic impairment For patients with a history of hepatic impairment, consider administering a lower dose. Do not administer to patients with severe hepatic impairment.

Child dose

Children and adolescents 6 years of age and older weighing 20 kg or more and less than 50 kg who can swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents 6 years of age and older weighing 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Pediatric patients under 6 years of age, pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡, and pediatric patients with hepatic impairment: Not recommended.

Precautions

This medication can cause serious harm to the fetus when taken during pregnancy, especially during the second and third trimesters, so usage should be discontinued immediately upon confirmation of pregnancy. Patients with allergic reactions to this medication, severely impaired liver function, those who are pregnant or may become pregnant, or patients with hereditary angioedema should not take this medication. Care must be taken when administering this medication to the elderly, those with reduced kidney function, and those with hyperkalemia, as there is a risk of blood pressure dropping too low; therefore, monitoring of their condition should be frequent. This medication can cause various side effects such as muscle cramps, dizziness, cough, dyspepsia, and, rarely, serious adverse reactions such as angioedema, hepatitis, and kidney failure. If symptoms such as a sudden drop in blood pressure or altered consciousness occur, usage should be stopped immediately and healthcare professionals consulted. Patients with impaired liver or kidney function may require dosage adjustments and should regularly test potassium levels in the blood to reduce the risk of hyperkalemia. This medication can interact with other antihypertensives, diuretics, potassium supplements, etc., so if other medications are being taken, healthcare professionals must be informed. Women who are pregnant or breastfeeding should avoid taking this medication, and if breastfeeding is unavoidable, they must discontinue it. This medication should not be administered to children, especially those under 6 years old or those with severely impaired kidney function. While taking this medication, regular monitoring of blood pressure, kidney function, and electrolyte status is necessary, and caution should be exercised for dizziness during driving or operating machinery. In the case of overdose, hypotension and bradycardia may occur, requiring immediate medical attention.

Side effects

Craniosynostosis, anuria, hypotension, renal failure, death, muscle cramps, back pain, leg pain, dizziness, congestion, upper respiratory infection, sinusitis, nausea, diarrhea, dyspepsia, cough, sinus disorder, pharyngitis, myalgia, insomnia, headache, weakness, fatigue, abdominal pain, chest pain, lip swelling, eyelid swelling, facial rash, exfoliation, hemolysis, facial edema, fever, orthostatic effects, syncope, angina, second-degree AV block, cerebrovascular accident, myocardial infarction, atrial fibrillation, palpitations, bradycardia, tachycardia, ventricular tachycardia, ventricular fibrillation, anorexia, constipation, toothache, dry mouth, flatulence, gastritis, vomiting, anemia, gout, upper limb pain, hip joint pain, joint swelling, knee pain, musculoskeletal pain, shoulder pain, muscle rigidity, arthralgia, arthritis, fibromyalgia, muscle weakness, anxiety, anxiety disorder, ataxia, confusion, depression, nightmare, sensory impairment, decreased libido, memory impairment, migraine, neuroexcitability, sensory disturbances, peripheral neuropathy, panic disorder, sleep disorder, hypersomnia, tremor, shortness of breath, bronchitis, pharyngeal discomfort, epistaxis, rhinitis, respiratory congestion, thoracic discomfort, hair loss, dermatitis, dry skin, petechial hemorrhage, erythema, flushing, photosensitivity reactions, itching, rash, sweating, urticaria, blurred vision, burning sensation in eyes and pain in eyes, conjunctivitis, dysgeusia, tinnitus, vision impairment, erectile dysfunction, nocturia, frequency, urethral infection, angioedema, vasculitis, anaphylactoid syndrome, liver dysfunction, hepatitis, intestinal vascular edema, lethargy, thrombocytopenia, elevated creatine kinase, rhabdomyolysis, acute renal failure, dry cough, erythroderma, hyponatremia, elevated ALT, syncope, loss of consciousness, acute hepatitis, fulminant hepatitis, ventricular extrasystole, arrhythmia, hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. Additionally, the medication should be placed in a dry area between 15 to 30 degrees Celsius to maintain its efficacy.

Appearance and packaging

Appearance

White oval film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.